- Home
- OMH vs RADX Comparison
OMH vs RADX Comparison
Compare OMH & RADX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OMH
- RADX
- Stock Information
- Founded
- OMH 2015
- RADX 2021
- Country
- OMH Singapore
- RADX Australia
- Employees
- OMH N/A
- RADX N/A
- Industry
- OMH Real Estate
- RADX
- Sector
- OMH Finance
- RADX
- Exchange
- OMH Nasdaq
- RADX NYSE
- Market Cap
- OMH 35.8M
- RADX 32.5M
- IPO Year
- OMH 2023
- RADX N/A
- Fundamental
- Price
- OMH $1.42
- RADX $4.20
- Analyst Decision
- OMH Hold
- RADX Strong Buy
- Analyst Count
- OMH 1
- RADX 2
- Target Price
- OMH N/A
- RADX $13.50
- AVG Volume (30 Days)
- OMH 147.1K
- RADX 17.8K
- Earning Date
- OMH 07-25-2025
- RADX 02-26-2025
- Dividend Yield
- OMH N/A
- RADX N/A
- EPS Growth
- OMH N/A
- RADX N/A
- EPS
- OMH N/A
- RADX N/A
- Revenue
- OMH $7,976,578.00
- RADX $204,609.00
- Revenue This Year
- OMH $28.40
- RADX N/A
- Revenue Next Year
- OMH $23.07
- RADX N/A
- P/E Ratio
- OMH N/A
- RADX N/A
- Revenue Growth
- OMH 117.53
- RADX N/A
- 52 Week Low
- OMH $0.59
- RADX $3.50
- 52 Week High
- OMH $6.20
- RADX $50.82
- Technical
- Relative Strength Index (RSI)
- OMH 47.16
- RADX N/A
- Support Level
- OMH $1.41
- RADX N/A
- Resistance Level
- OMH $1.56
- RADX N/A
- Average True Range (ATR)
- OMH 0.10
- RADX 0.00
- MACD
- OMH 0.03
- RADX 0.00
- Stochastic Oscillator
- OMH 63.90
- RADX 0.00
About OMH Ohmyhome Limited
Ohmyhome Ltd is a data and technology-driven property technology company based in Singapore. Through its subsidiaries, it operates a one-stop-shop property platform that provides end-to-end property solutions and services for its customers, which comprises brokerage services and emerging and other services, such as home renovation and furnishing services, listing and research, mortgage referral, legal services, and insurance referral services. The company derives its revenues from two sources: revenue from brokerage services, property management services, and revenue from emerging and other services.
About RADX RADIOPHARM THERANOSTICS LIMITED SPON ADS EACH REP 300 ORD
Radiopharm Theranostics Ltd is an Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialization of health technologies.